Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab after Resection of Liver Metastases from Colorectal Cancer in RAS Wild-type Patients
2010-023671-26Phase 2Completed
- Sponsor
- LMU Klinikum
- Start
- May 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of panitumumab in colorectal cancer (CRC) (2 arms), sponsored by LMU Klinikum. Primary endpoint: Progression-free survival (PFS) rate at 2 years. Started May 2011; status: completed.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2010-023671-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023671-26.